Paracrine factors, which are regarded as key regulator benefitting CDCs therapeutic effect in heart diseases, were highly expressed in iECDCs [chemokine (C-X-C motif) ligand 12 (CXCL12), VEGF, FGF, IGFBP4, etc.] (Figure 3A). This evidence concerns the gene IGFBP4 and heart disorder.